SpringWorks Therapeutics - 51 Year Dividend History | SWTX

Historical dividend payout and yield for SpringWorks Therapeutics (SWTX) since 1971. The current TTM dividend payout for SpringWorks Therapeutics (SWTX) as of May 27, 2022 is $0.00. The current dividend yield for SpringWorks Therapeutics as of May 27, 2022 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.907B $0.035B
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
Stock Name Country Market Cap PE Ratio